A network meta-analysis of 7155 NSCLC patients showed that the combination of chemotherapy plus PD-L1 inhibitors plus dexamethasone pretreatment may be a candidate for the first-line treatment of NSCLC patients (147). Here, CD274 is linked to non-small cell lung carcinoma.